App Note: High-Throughput Raman Analysis of Protein Glycosylation
The market for monoclonal antibody (MAb) therapeutics is projected to reach a value of USD $350 billion by the end of 2027. The production and purification of MAbs can be challenging. These molecules are prone to several types of post-translational modifications that may reduce their efficacy and limit shelf life. The most prevalent modifications include glycosylation, misfolding, aggregation, oxidation, deamidation, and proteolysis. Over one-third of MAb and recombinant protein therapeutic agents are glycoproteins3 and glycosylation is one of the most common post-translational modifications in these biopharmaceuticals.
If you would like to discuss your application and are considering adopting spectroscopy as a process analytic technology, please contact us at firstname.lastname@example.org.